Molecular cancer therapy: Decorin, a small leucine-rich proteoglycan, suppresses the expression of SPOP via down regulation of its target gene, 27/April/2014, 6.44 am

The arthritis drug Withaferin A (WFA) suppresses the expression of tumor suppressor RECK via up regulation of its target gene, 27/April/2014, 5.51 am
April 27, 2014
Insights into the regulation of invasion, metastasis, and angiogenesis: The induced pluripotent stem cell gene Lin-28 increases the expression of MMP-14 via down regulation of its target gene, 27/April/2014, 6.54 am
April 27, 2014
Show all

A recent study from University of Chicago (Illinois, USA) shows that SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub…” This study was published in the prestigious  Journal Cancer Cell (One of the top journal in Cancer Biology).” 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular cancer therapy: Decorin, a small leucine-rich proteoglycan, suppresses the expression of SPOP via down regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Decorin, a small leucine-rich proteoglycan, suppresses the expression of SPOP via down regulation of its target gene, 27/April/2014, 6.44 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.